Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart

Journal of Magnetic Resonance Imaging

Volumn 21, Issue 5, 2005, Pages 536-545

  Simor, Tamás ^a,b   Gaszner, Balázs ^a,b   Oshinski, John N ^c   Waldrop, Sandra M ^c   Pettigrew, Roderic I ^c   Horváth, Iván G ^b   Hild, Gábor ^a,b   Elgavish, Gabriel A ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Elgavish Paramagnetics Inc   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Heart; Magnetic resonance imaging (MRI); MRI contrast agents; Myocardium; Perfusion

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; N (2 BUTYRYLOXYETHYL) N' (2 ETHYLOXYETHYL) N,N' BIS[N'',N'' BIS(CARBOXYMETHYL)ACETAMIDO] 1,2 ETHANEDIAMINE GADOLINIUM COMPLEX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DOG; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; IMAGE ANALYSIS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION INJURY;

ANALYSIS OF VARIANCE; ANIMALS; CONTRAST MEDIA; DOGS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 17844379273     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20326     Document Type: Article

References (41)

1. Saeed M. New concepts in characterization of ischemically injured myocardium by MRI. Exp Biol Med (Maywood) 2001;226:367-376.
2. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105: 224-229.
3. Schalla S, Higgins CB, Saeed M. Contrast agents for cardiovascular magnetic resonance imaging. Current status and future directions. Drugs Dev Res 2002;3:285-302.
4. Saeed M, Wendland MF, Szolar D, et al. Quantification of the extent of area at risk with fast contrast-enhanced magnetic resonance imaging in experimental coronary artery stenosis. Am Heart J 1996;132:921-932.
5. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
6. Mahrholdt H, Wagner A, Judd RM, Sechtem U. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002;23:602-619.
7. Saeed M, Wendland MF, Sakuma H, et al. Coronary artery stenosis: detection with contrast-enhanced MR imaging in dogs. Radiology 1995;196:79-84.
8. Schwitter J, Saeed M, Wendland MF, et al. Assessment of myocardial function and perfusion in a canine model of non-occlusive coronary artery stenosis using fast magnetic resonance imaging. J Magn Reson Imaging 1999;9:101-110.
9. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 1991;18:959-965.
10. Lauerma K, Virtanen KS, Sipila LM, Hekali P, Aronen HJ. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 1997;96:2859-2867.
11. Matheijssen NA, Louwerenburg HW, van Rugge FP, et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole sestamibi SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med 1996;35: 221-228.
12. Walsh EG, Doyle M, Lawson MA, Blackwell GG, Pohost GM. Multislice first-pass myocardial perfusion imaging on a conventional clinical scanner. Magn Reson Med 1995;34:39-47.
13. Bertschinger KM, Nanz D, Buechi M, et al. Magnetic resonance myocardial first-pass perfusion imaging: parameter optimization for signal response and cardiac coverage. J Magn Reson Imaging 2001;14:556-562.
14. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-2235.
15. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.
16. Kostler H, Sandstede JJ, Lipke C, Landschutz W, Beer M, Hahn D. Auto-SENSE perfusion imaging of the whole human heart. J Magn Reson Imaging 2003;18:702-708.
17. Jerosch-Herold M, Wilke N, Wang Y, et al. Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group. Int J Card Imaging 1999;15:453-464.
18. Bjornerud A, Johansson LO, Bruey-Saebo K, Ahlstrom HK. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange. Magn Reson Med 2002;47:461-471.
19. Saab-Ismail NH, Simor T, Gaszner B, Lorand T, Szöllösy M, Elgavish GA. Synthesis and in vivo evaluation of new contrast agents for cardiac MRI. J Med Chem 1999;42:2852-2861.
20. Suranyi P, Kiss P, Brott BC, Simor T, Elgavish A, Elgavish GA. Determining tissue kinetics of Gd(ABE-DTTA), an infarct-avid, persistent contrast-agent in canine myocardial infarction. In: Proceedings of the 12th Annual Meeting of ISMRM. Kyoto, Japan, 2004. Abstract 1836.
21. Pettigrew RI, Oshinski JN, Chatzimavroudis G, Dixon WT. MRI techniques for cardiovascular imaging. J Magn Reson Imaging 1999;10:590-601.
22. Kowallik P, Schulz R, Guth BD, et al. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 1991;83:974-982.
23. Carr DH, Brown J, Bydder GM, et al. Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR Am J Roentgenol 1984;143:215-224.
24. Wesbey GE, Higgins CB, McNamara MT, et al. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology 1984;153:165-169.
25. McNamara MT, Higgins CB, Ehman RL, Revel D, Sievers R, Brasch RC. Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA. Radiology 1984;153:157-163.
26. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection. quantitative, first-pass MR imaging. Radiology 1997;204:373-384.
27. Schwitter J, Debatin JF, von Schulthess GK, McKinnon GC. Normal myocardial perfusion assessed with multishot echo-planar imaging. Magn Reson Med 1997;37:140-147.
28. Muhling O, Jerosch-Herold M, Nabauer M, Wilke N. Assessment of ischemic heart disease using magnetic resonance first-pass perfusion imaging. Herz 2003;28:82-89.
29. Wu KC. Myocardial perfusion imaging by magnetic resonance imaging. Curr Cardiol Rep 2003;5:63-68.
30. Gerber BL, Bluemke DA, Chin BB, et al. Single-vessel coronary artery stenosis: myocardial perfusion imaging with Gadomer-17 first-pass MR imaging in a swine model of comparison with gadopentetate dimeglumine. Radiology 2002;225:104-112.
31. Brasch RC, Moseley ME, Dupon J, et al. Macromolecular magnetic resonance imaging contrast media. Accumulated experience. Invest Radiol 1990;25:551-552.
32. Schmiedl U, Brasch RC, Ogan MD. Moseley ME. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. Acta Radiol Suppl 1990;374:99-102.
33. Baxter AB, Melnikoff S, States DP, Brasch RC. AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals. Invest Radiol 1991;26:1035-1040.
34. Roberts HC, Saeed M, Roberts TP, et al. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability. J Magn Reson Imaging 1997;7:331-338.
35. Kraitchman DL, Chin BB, Heldman AW, Solaiyappan M, Bluemke DA. MRI detection of myocardial perfusion defects due to coronary artery stenosis with MS-325. J Magn Reson Imaging 2002;15:149-158.
36. Dewey M, Kaufels N, Laule M, et al. Magnetic resonance imaging of myocardial perfusion and viability using a blood pool contrast agent. Invest Radiol 2004;39:498-505.
37. Simor T, Chu WJ, Johnson L, et al. In vivo MRI visualization of acute myocardial ischemia and reperfusion in ferrets by the persistent action of the contrast agent Gd (BME-DTTA). Circulation 1995;92:3549-3559.
38. Szolar DH, Saeed M, Wendland MF, et al. MR imaging characterization of postischemic myocardial dysfunction ("stunned myocardium"): relationship between functional and perfusion abnormalities. J Magn Reson Imaging 1996;6:615-624.
39. Szolar DH, Saeed M, Wendland M, et al. Quantification of area at risk during coronary occlusion and reperfusion by means of MR perfusion imaging. Acta Radiol 1997;38:479-488.
40. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977;55:294-302.
41. Travin MI, Bergmann SR. Assessment of myocardial viability. Semin Nucl Med 2005;35:2-16.